PodParley PodParley
PodParley
Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study episode artwork

EPISODE · May 20, 2024 · 13 MIN

Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study

from JACC This Week

Commentary by Dr. Valentin Fuster

Episode metadata supplied by the publisher feed · Published May 20, 2024

Embed this episode

NOW PLAYING

Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study

0:00 13:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JACC This Week?

This episode is 13 minutes long.

When was this JACC This Week episode published?

This episode was published on May 20, 2024.

Can I download this JACC This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!